US based Novavax on Monday stated that its nano-particle protein based Covid-19 vaccine applicant has demonstrated an general 90.four per...
Novavax
US based Novavax on Monday stated that its nano-particle protein based Covid-19 vaccine applicant has demonstrated an general 90.four per...